Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02694822
Brief Title: AGEN1884, an Anti-CTLA-4 Human Monoclonal Antibody in Subjects With Advanced or Refractory Cancer and Who Have Progressed With PD-1/PD-L1 Inhibitor as Their Most Recent Therapy

First Submitted : February 12, 2016
First Submitted that Met QC Criteria : February 24, 2016
First Posted : March 1, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : January 29, 2021
Last Update Posted : February 2, 2021